- Report
- November 2025
Global
From €450EUR$539USD£409GBP
- Report
- November 2025
Global
From €200EUR$239USD£182GBP
- Report
- June 2025
- 80 Pages
From €3086EUR$3,450USD£2,714GBP
- Report
- October 2024
- 83 Pages
Global
From €4339EUR$4,850USD£3,815GBP
- Report
- September 2024
- 118 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- January 2024
- 150 Pages
Global
€4469EUR$4,995USD£3,929GBP
- Report
- January 2024
- 201 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- October 2023
- 85 Pages
United States
From €4339EUR$4,850USD£3,815GBP
- Report
- August 2023
- 180 Pages
Global
From €3355EUR$3,750USD£2,950GBP
- Report
- July 2023
- 100 Pages
Global
From €4339EUR$4,850USD£3,815GBP
- Report
- September 2022
Global
€4990EUR$5,975USD£4,541GBP
- Report
- June 2022
- 220 Pages
Global
From €3086EUR$3,450USD£2,714GBP
- Report
- November 2020
- 450 Pages
Global
From €4384EUR$4,900USD£3,854GBP
- Report
- September 2020
- 700 Pages
Global
From €4384EUR$4,900USD£3,854GBP
- Report
- August 2019
- 42 Pages
Global
€2679EUR$2,995USD£2,356GBP
- Report
- November 2022
- 71 Pages
Global
From €3131EUR$3,500USD£2,753GBP
- Report
- August 2024
- 84 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Report
- January 2024
- 174 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Report
- January 2024
- 85 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Report
- March 2022
- 84 Pages
Global
From €3500EUR$4,191USD£3,185GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more